Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Phenotypical evaluation of lymphocytes and monocytes in patients with type 2 diabetes mellitus in Saudi Arabia

Mamdouh Allahyani, Amani M. Alshalawi, Maram R. Alshalawii, Shahad A. Alqorashi, Abdulelah Aljuaid, Mazen M. Almehmadi, Mohammed A. Bokhary, Alhanouf S. Albrgey, Ahmad A. Alghamdi, Abdullah F. Aldairi and Ayman S. Alhazmi
Saudi Medical Journal March 2023, 44 (3) 296-305; DOI: https://doi.org/10.15537/smj.2023.44.3.20220873
Mamdouh Allahyani
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Amani M. Alshalawi
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maram R. Alshalawii
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahad A. Alqorashi
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdulelah Aljuaid
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mazen M. Almehmadi
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed A. Bokhary
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alhanouf S. Albrgey
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmad A. Alghamdi
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdullah F. Aldairi
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayman S. Alhazmi
From the Department of Clinical Laboratory Sciences (Allahyani, Alshalawi, Alshalawii, Alqorashi, Aljuaid, Almehmadi, Alghamdi, Alhazmi), College of Applied Medical Sciences, Taif University, from the Department of Clinical Chemistry (Bokhar); from the Department of Endocrinology and Diabetic Centre (Albrgey), King Abdulaziz specialist hospital, Ministry of Health, Taif, and from the Department of Laboratory Medicine (Aldairi), Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    - Percentage of lymphocytes in T2DM patients and healthy individuals. Lymphocytes were isolated from the peripheral blood of the T2DM patients and healthy individuals based on SSC and FSC using flow cytometry. A) Dot plots showing the percentage of lymphocytes in the samples obtained from healthy individuals and T2DM patients. B) The percentage of lymphocytes in both groups is presented. Data were analyzed using an unpaired t-test. Values are presented as mean±SD. ***p≤0.001, T2DM: type 2 diabetes mellitus, SSC: side scatter, FSC: forward scatter

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    - Levels of B-lymphocytes and their subsets in T2DM patients and healthy individuals. Lymphocytes were isolated from the peripheral blood of the T2DM patients and healthy individuals. The cells were then stained with anti-CD19 (FITC), CD27 (PerCyp Cy5.5), and CD38 (APC) and analyzed using flow cytometry. A) Representative dot plots showing the percentage of CD19+ B-cells in the samples obtained from healthy individuals and T2DM patients. B) The percentage of CD19+ cells in both groups is presented. C) Representative dot plots showing the percentage of B-cell subsets in the samples obtained from healthy individuals and T2DM according to CD27 and CD38 expression. D) The percentage of CD27-/CD38+ cells in both groups is presented. E) The percentage of CD27+/CD38- cells in both groups is presented. Data were analyzed using an unpaired t-test. Values are presented as mean±SD. ***p≤0.001, ****p≤0.0001, T2DM: type 2 diabetes mellitus

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    - Levels of T-lymphocytes and subsets in T2DM patients and healthy individuals. Lymphocytes were isolated from the peripheral blood of T2DM patients and healthy individuals. The cells were then stained with anti-CD3 (APC Cy7), CD4 (APC), and CD8 (PE) and analyzed using flow cytometry. A) Dot plots showing the percentage of CD3+ T-cells in the samples obtained from healthy individuals and T2DM patients. B) The percentage of CD3+ cells in both groups is presented. C) Dot plots showing the percentage of CD4 and CD8 T-cells in the samples obtained from healthy individuals and T2DM patients. D) The percentage of CD4+ cells; and E) CD8+ cells in both groups is presented. Data were analyzed using an unpaired t-test. Values are presented as mean±SD. *p≤0.05, T2DM: type 2 diabetes mellitus

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    - Levels of NK cells in T2DM patients and healthy individuals. Lymphocytes were isolated from the peripheral blood of the T2DM patients and healthy individuals. The cells were then stained with anti-CD3 (APC Cy7), and CD56 (PE) and analyzed using flow cytometry. A) Dot plots showing the percentage of CD3-/CD56+ NK cells in the samples obtained from healthy individuals and T2DM patients. B) The percentage of NK cells in both groups is presented. Data were analyzed using an unpaired t-test. Values are presented as mean±SD. **p≤0.01, T2DM: type 2 diabetes mellitus

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    - Expression of monocyte subsets in T2DM patients and healthy individuals. Monocytes were isolated from the peripheral blood of the T2DM patients and healthy individuals. The cells were then stained with anti-CD14 (APC Cy7), and CD16 (FITC) and analyzed using flow cytometry. A) Dot plots showing the percentage of monocyte subsets in the samples obtained from healthy individuals and T2DM patients. B) The percentage of CD14+ cells; C) CD14+/CD16+; and D) CD16+ in both groups are presented. Data were analyzed using an unpaired t-test. Values are presented as mean±SD. *p≤0.05, ***p≤0.001. T2DM: type 2 diabetes mellitus

Tables

  • Figures
    • View popup
    Table 1

    - Patient sample characteristics.

    ParametersT2DMHealthy controls
    Age (years), mean±SD59±9.146±5.3
    Gender  
    MaleFemale33 (53.2)29 (46.8)19 (57.5)14 (42.5)
    HbA1c (%), mean±SD8.6±2.35.3±1.4
    • Values are presented as numbers and precentages (%) or mean ± standard deviation (SD). HbA1c: hemoglobin A1c, T2DM: type 2 diabetes mellitus

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 44 (3)
Saudi Medical Journal
Vol. 44, Issue 3
1 Mar 2023
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phenotypical evaluation of lymphocytes and monocytes in patients with type 2 diabetes mellitus in Saudi Arabia
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Phenotypical evaluation of lymphocytes and monocytes in patients with type 2 diabetes mellitus in Saudi Arabia
Mamdouh Allahyani, Amani M. Alshalawi, Maram R. Alshalawii, Shahad A. Alqorashi, Abdulelah Aljuaid, Mazen M. Almehmadi, Mohammed A. Bokhary, Alhanouf S. Albrgey, Ahmad A. Alghamdi, Abdullah F. Aldairi, Ayman S. Alhazmi
Saudi Medical Journal Mar 2023, 44 (3) 296-305; DOI: 10.15537/smj.2023.44.3.20220873

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phenotypical evaluation of lymphocytes and monocytes in patients with type 2 diabetes mellitus in Saudi Arabia
Mamdouh Allahyani, Amani M. Alshalawi, Maram R. Alshalawii, Shahad A. Alqorashi, Abdulelah Aljuaid, Mazen M. Almehmadi, Mohammed A. Bokhary, Alhanouf S. Albrgey, Ahmad A. Alghamdi, Abdullah F. Aldairi, Ayman S. Alhazmi
Saudi Medical Journal Mar 2023, 44 (3) 296-305; DOI: 10.15537/smj.2023.44.3.20220873
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Exploring communication challenges with children and parents among pharmacists in Saudi Arabia
  • Exploring hypothyroidism’s effects on lipid profiles
  • Assessment of asthma control levels in a tertiary hospital
Show more Original Article

Similar Articles

Keywords

  • lymphocytes
  • monocytes
  • T2DM

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire